A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Clinical trial NCT00038545 · COMPLETED
Trial details
- NCT number
- NCT00038545
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-18
- Primary completion
- 2004-04-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.